B

Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315

Watchlist Manager
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Watchlist
Price: 5.6 HKD -2.78%
Market Cap: 2.2B HKD
Have any thoughts about
Biocytogen Pharmaceuticals Beijing Co Ltd?
Write Note

Biocytogen Pharmaceuticals Beijing Co Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biocytogen Pharmaceuticals Beijing Co Ltd
Long-Term Investments Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
B
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Long-Term Investments
ÂĄ188.4m
CAGR 3-Years
165%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Long-Term Investments
ÂĄ635.2m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Long-Term Investments
ÂĄ1.4B
CAGR 3-Years
89%
CAGR 5-Years
126%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Long-Term Investments
ÂĄ17B
CAGR 3-Years
8%
CAGR 5-Years
117%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Long-Term Investments
ÂĄ295.2m
CAGR 3-Years
8%
CAGR 5-Years
27%
CAGR 10-Years
77%
Imeik Technology Development Co Ltd
SZSE:300896
Long-Term Investments
ÂĄ1.9B
CAGR 3-Years
216%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Biocytogen Pharmaceuticals Beijing Co Ltd's Long-Term Investments?
Long-Term Investments
188.4m CNY

Based on the financial report for Dec 31, 2023, Biocytogen Pharmaceuticals Beijing Co Ltd's Long-Term Investments amounts to 188.4m CNY.

What is Biocytogen Pharmaceuticals Beijing Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
165%

Over the last year, the Long-Term Investments growth was -5%. The average annual Long-Term Investments growth rates for Biocytogen Pharmaceuticals Beijing Co Ltd have been 165% over the past three years .

Back to Top